Monoclonal therapies, the EU focuses on three drugs

Three new drugs. All made in the EU. And all capable of intervening on Covid-19 at every stage of the disease. The European Commission is currently giving the green light to a project that will make monoclonal therapies against Coronavirus a concrete strategy and not a limited action. In fact, at the moment this type of medicines are not only very expensive, but they are especially effective particularly in the initial phase of the infection.